# NISCI - Nogo Inhibition in Spinal Cord Injury

> **NCT03935321** · PHASE2 · COMPLETED · sponsor: **University of Zurich** · enrollment: 129 (actual)

## Conditions studied

- Spinal Cord Injury, Acute

## Interventions

- **DRUG:** NG-101
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03935321
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-15
- **Primary completion:** 2023-02-02
- **Final completion:** 2023-02-02
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2023-04-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03935321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03935321, "NISCI - Nogo Inhibition in Spinal Cord Injury". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03935321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*